Donadio Stefano, Carrano Lucia, Brandi Letizia, Serina Stefania, Soffientini Adolfo, Raimondi Elena, Montanini Nicoletta, Sosio Margherita, Gualerzi Claudio O
Biosearch Italia, via R. Lepetit 34, 21040 Gerenzano(VA), Italy.
J Biotechnol. 2002 Nov 13;99(3):175-85. doi: 10.1016/s0168-1656(02)00208-0.
The increasing frequency of nosocomial infections due to multi-resistant pathogens exerts a significant toll and calls for novel and better antibiotics. Different approaches can be used in the search for novel antibiotics acting on drug-resistant bacterial pathogens. We present some considerations on valid bacterial targets to be used for searching new antibiotics, and how the information from bacterial genome sequences can assist in choosing the appropriate targets. Other factors to be considered in target selection are the chemical diversity available for screening and its uniqueness. We will conclude discussing our strategy for searching novel antibacterials. This is based on a large collection of microbial extracts as a source of chemical diversity and on the use of specific targets essential for the viability of bacterial pathogens. Two assay strategies have been implemented: a pathway-based assay, where a series of essential bacterial targets is screened in a single assay; and a binding assay, where many targets can be screened individually in the same format.
多重耐药病原体导致的医院感染频率不断增加,造成了巨大损失,因此需要新型且更好的抗生素。在寻找作用于耐药细菌病原体的新型抗生素时,可以采用不同的方法。我们提出了一些关于用于寻找新抗生素的有效细菌靶点的考虑因素,以及细菌基因组序列信息如何有助于选择合适的靶点。靶点选择中要考虑的其他因素是可用于筛选的化学多样性及其独特性。我们将在讨论寻找新型抗菌药物的策略时得出结论。这一策略基于大量微生物提取物作为化学多样性的来源,并基于使用对细菌病原体生存至关重要的特定靶点。已经实施了两种检测策略:一种基于途径的检测方法,即在单一检测中筛选一系列必需的细菌靶点;另一种是结合检测方法,即可以以相同形式单独筛选许多靶点。